Investigating the role of epigenetics in cancer development and potential therapeutic interventions.

Thesis Abstract

Abstract
Cancer remains a leading cause of morbidity and mortality worldwide, with an urgent need for novel treatment strategies. Epigenetics, the study of heritable changes in gene expression that do not involve alterations in the DNA sequence, has emerged as a key player in cancer development and progression. This thesis aims to investigate the role of epigenetics in cancer development and explore potential therapeutic interventions targeting epigenetic mechanisms. The introduction provides a comprehensive overview of cancer biology, highlighting the importance of epigenetic alterations in driving tumorigenesis. The background of the study delves into the molecular mechanisms underlying epigenetic modifications, such as DNA methylation, histone modifications, and non-coding RNAs, and their impact on gene expression in cancer cells. The problem statement emphasizes the need to elucidate the specific epigenetic changes that contribute to cancer initiation and progression, as well as the challenges associated with targeting these alterations for therapeutic purposes. The objectives of the study are to identify key epigenetic modifications associated with different types of cancer, investigate the functional consequences of these alterations, and evaluate the efficacy of epigenetic-targeted therapies in preclinical models. The limitations of the study include the complexity of epigenetic regulatory networks, the heterogeneity of cancer genomes, and the lack of validated biomarkers for patient stratification. The scope of the study encompasses in vitro and in vivo experiments using cancer cell lines and animal models, as well as clinical data analysis to correlate epigenetic profiles with patient outcomes. The significance of the study lies in its potential to uncover novel epigenetic vulnerabilities in cancer cells that can be exploited for the development of precision medicine approaches. The structure of the thesis is organized into five chapters, with detailed discussions on the introduction, literature review, research methodology, findings, and conclusion. The literature review synthesizes existing knowledge on epigenetic alterations in various types of cancer, highlighting common themes and discrepancies in the field. The research methodology outlines the experimental approaches used to investigate epigenetic changes in cancer cells, including next-generation sequencing, chromatin immunoprecipitation assays, and drug screening studies. The discussion of findings presents the results of epigenetic profiling in cancer cells, the identification of key epigenetic drivers of tumorigenesis, and the evaluation of novel epigenetic-targeted therapies. Finally, the conclusion and summary of the thesis highlight the key findings, implications for cancer treatment, and future directions for research in the field of epigenetics and cancer. In conclusion, this thesis sheds light on the intricate interplay between epigenetic modifications and cancer development, providing valuable insights into potential therapeutic strategies for combating this deadly disease. Through a multidisciplinary approach combining molecular biology, bioinformatics, and clinical research, this study contributes to the growing body of knowledge on epigenetics and its implications for precision oncology.